Alzheimer's blood tests may predict symptoms years in advance, but experts urge caution

A caller activity of humor tests aiming to foretell Alzheimer’s consequence whitethorn connection dream for earlier discovery — but they could besides raise concerns astir nan accuracy and reliability of nan results.

A caller study funded by nan National Institutes of Health evaluated a blood test measuring levels of p-tau217 (phosphorylated tau 217), a macromolecule that accumulates successful nan encephalon during Alzheimer’s disease.

In a group of complete 600 older adults without symptoms, repeated humor tests were recovered to foretell nan property of denotation onset pinch a median absolute correction of astir 3 to 4 years. Higher levels of p-tau217 were associated pinch earlier emergence of symptoms.

‘HIDDEN’ FAT COULD PREDICT ALZHEIMER’S DISEASE UP TO 20 YEARS BEFORE SYMPTOMS, RESEARCH FINDS

Someone whose p-tau217 levels are elevated astatine property 60 would typically create symptoms astir 20 years later, nan researchers found. If p-tau217 becomes elevated astatine property 80, symptoms thin to look overmuch sooner, aft astir 11 years.

A caller activity of humor tests aiming to foretell Alzheimer’s consequence whitethorn connection dream for earlier discovery — but they could besides raise concerns astir nan accuracy and reliability of nan results. (iStock)

The findings, published successful Nature Medicine, request to beryllium validated successful broader and much divers populations, nan researchers noted. The test's predictive accuracy whitethorn not yet beryllium capable for individual objective use.

"In nan adjacent term, these models will accelerate our investigation and clinical trials," said lead interrogator Dr. Suzanne Schindler astatine Washington University successful St. Louis successful an NIH property release. 

ALZHEIMER'S RATES HAVE REACHED STAGGERING NUMBER AS EXPERTS CALL FOR CHANGE

"Eventually, nan extremity is to beryllium capable to estimate erstwhile individuals are apt to create symptoms, which will thief them and their doctors to create a scheme to prevent aliases slow symptoms."

As much Alzheimer’s treatments are becoming available, location is simply a increasing request for biomarker confirmation of nan disease, according to Sheena Aurora, MD, vice president of aesculapian affairs for nan Alzheimer's Association successful Chicago.

"We do not urge nan usage of humor biomarker tests successful group who are not experiencing symptoms."

"Blood-based biomarker tests tin amended nan accuracy and velocity of test erstwhile utilized arsenic a complement to different testing, offering a way to earlier Alzheimer’s detection," Aurora told Fox News Digital.

The tests are comparatively inexpensive and easier to entree compared to PET scans aliases MRI, according to nan expert.

DEMENTIA REPORT REVEALS 'SHOCKING' SIGNS AT AGE 60 THAT YOU'LL DEVELOP THE DISEASE BY AGE 80

"For many, early discovery tin bring bid of mind, clip to scheme ahead, agency complete decisions and nan opportunity to effort treatments that slow illness progression," she said.

DEMENTIA RISK FOR PEOPLE 55 AND OLDER HAS DOUBLED, NEW STUDY FINDS

Two Alzheimer’s humor tests person been cleared by nan FDA – nan Fujirebio Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, cleared for symptomatic adults 55 and older, and nan Roche Elecsys pTau181 Plasma, cleared for first appraisal successful superior attraction for adults 55 and complete pinch symptoms of cognitive decline.

Several different lab-developed tests are besides emerging – but not each tests are nan same, and they do person limitations, Aurora noted.

"Blood-based biomarker tests tin amended nan accuracy and velocity of test erstwhile utilized arsenic a complement to different testing, offering a way to earlier Alzheimer’s detection." (iStock)

The Alzheimer’s Association’s objective guidelines urge utilizing humor tests chiefly successful specialized attraction settings for patients pinch cognitive impairment, arsenic that is presently nan only discourse wherever beardown grounds supports their effective use, according to Aurora.

"We do not urge nan usage of humor biomarker tests successful group who are not experiencing symptoms," she said. "There presently is not substantive information astir usage of these tests successful superior attraction settings aliases for group who are not cognitively impaired."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Diagnosing Alzheimer’s is typically a "multi-step process" involving respective types of tests, Aurora noted, but humor testing tin beryllium an important portion of nan diagnostic process.

"Current Alzheimer’s humor biomarker tests are not a standalone trial to diagnose Alzheimer’s illness – specified a point does not yet exist," she said.

Diagnosing Alzheimer’s is typically a "multi-step process" involving respective types of tests, an master noted, but humor testing tin beryllium an important portion of nan diagnostic process. (iStock)

Blood tests are not a substitute for a broad objective evaluation, nan master noted, "and they should beryllium ordered and interpreted by a healthcare master successful nan discourse of objective care."

The Alzheimer’s Association’s guidelines besides pass that accuracy tin alteration wide among tests, and that galore humor biomarker options connected nan marketplace autumn short of recommended capacity standards.

CLICK HERE FOR MORE HEALTH STORIES

There is besides a consequence of mendacious positives, which tin origin significant anxiety, experts warn. 

Research shows that group pinch chronic kidney disease, for example, whitethorn person higher levels of Alzheimer’s humor biomarkers, moreover erstwhile nan illness is not present. This underscores nan value of healthcare providers cautiously analyzing nan trial results.

Experts accent nan request for amended acquisition for some patients and providers — on pinch clear objective follow-up aft results. (iStock)

As new research continues to show nan committedness of humor tests, Aurora stressed nan request for amended acquisition for some patients and providers — on pinch clear objective follow-up aft results — to afloat recognize their imaginable crossed different attraction settings.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

"Studies successful these areas are being conducted, and we expect to study much astatine nan 2026 Alzheimer’s Association International Conference (AAIC 2026), July 12-15 successful London and online," she added.

Aurora noted that nan Alzheimer’s Screening and Prevention (ASAP) Act intends to grow entree to caller humor tests by creating a pathway for Medicare to screen FDA-approved aliases cleared humor biomarker screening tests. 

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Under existent law, Medicare tin only screen preventive services if Congress authorizes them aliases national guidelines urge them, a limitation that has delayed sum of emerging Alzheimer’s tests.